Skip to Main content Skip to Navigation
Journal articles

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-02532895
Contributor : Angélique GOUGELET Connect in order to contact the contributor
Submitted on : Thursday, April 28, 2022 - 12:06:34 PM
Last modification on : Tuesday, May 3, 2022 - 3:34:27 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

André Lechel, Angélique Gougelet. Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?. Gut, BMJ Publishing Group, 2016, 65 (7), pp.1073-1074. ⟨10.1136/gutjnl-2016-311446⟩. ⟨inserm-02532895⟩

Share

Metrics

Record views

60